- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 4 x 1N7: CHAPSO(Non-covalent)
1N7.3: 9 residues within 4Å:- Chain A: Q.119, M.120
- Chain C: P.132, G.133, L.135, S.136
- Ligands: PX4.12, PX4.34, PX4.35
4 PLIP interactions:3 interactions with chain C, 1 interactions with chain A- Hydrophobic interactions: C:L.135, A:Q.119
- Hydrogen bonds: C:L.135, C:S.136
1N7.16: 9 residues within 4Å:- Chain B: Q.119, M.120
- Chain D: P.132, G.133, L.135, S.136
- Ligands: PX4.25, PX4.47, PX4.48
4 PLIP interactions:3 interactions with chain D, 1 interactions with chain B- Hydrophobic interactions: D:L.135, B:Q.119
- Hydrogen bonds: D:L.135, D:S.136
1N7.29: 9 residues within 4Å:- Chain B: P.132, G.133, L.135, S.136
- Chain C: Q.119, M.120
- Ligands: PX4.21, PX4.22, PX4.38
4 PLIP interactions:1 interactions with chain C, 3 interactions with chain B- Hydrophobic interactions: C:Q.119, B:L.135
- Hydrogen bonds: B:L.135, B:S.136
1N7.42: 9 residues within 4Å:- Chain A: P.132, G.133, L.135, S.136
- Chain D: Q.119, M.120
- Ligands: PX4.8, PX4.9, PX4.51
4 PLIP interactions:1 interactions with chain D, 3 interactions with chain A- Hydrophobic interactions: D:Q.119, A:L.135
- Hydrogen bonds: A:L.135, A:S.136
- 36 x PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
PX4.4: 18 residues within 4Å:- Chain A: M.192, P.196, W.199, I.203, F.207
- Chain D: M.141, T.142, G.168, E.169, F.171, Y.172, F.175, M.213, L.216
- Ligands: PX4.18, LMT.40, PX4.46, PX4.47
Ligand excluded by PLIPPX4.5: 14 residues within 4Å:- Chain A: G.30, I.31, G.34, L.35, S.38, T.40
- Chain C: T.142, Y.146, T.166, L.167, G.168
- Ligands: PX4.11, PX4.12, PX4.17
Ligand excluded by PLIPPX4.6: 13 residues within 4Å:- Chain A: P.79, W.80, F.83, F.111, V.114, S.125, I.128, I.131, P.132
- Ligands: PX4.7, PX4.8, PX4.9, PX4.10
Ligand excluded by PLIPPX4.7: 9 residues within 4Å:- Chain A: F.99
- Chain C: V.200, I.203, F.207
- Ligands: PX4.6, PX4.8, LMT.28, PX4.30, PX4.50
Ligand excluded by PLIPPX4.8: 7 residues within 4Å:- Ligands: PX4.6, PX4.7, PX4.9, PX4.30, 1N7.42, PX4.50, PX4.51
Ligand excluded by PLIPPX4.9: 5 residues within 4Å:- Ligands: PX4.6, PX4.8, PX4.10, 1N7.42, PX4.50
Ligand excluded by PLIPPX4.10: 8 residues within 4Å:- Chain A: K.77, P.79, L.82, F.83, F.86, I.90
- Ligands: PX4.6, PX4.9
Ligand excluded by PLIPPX4.11: 6 residues within 4Å:- Chain B: Y.197
- Ligands: PX4.5, PX4.12, PX4.33, PX4.34, PX4.35
Ligand excluded by PLIPPX4.12: 8 residues within 4Å:- Chain A: I.23, V.27, V.117, Q.119
- Ligands: 1N7.3, PX4.5, PX4.11, PX4.34
Ligand excluded by PLIPPX4.17: 18 residues within 4Å:- Chain B: M.192, P.196, W.199, I.203, F.207
- Chain C: M.141, T.142, G.168, E.169, F.171, Y.172, F.175, M.213, L.216
- Ligands: PX4.5, LMT.27, PX4.33, PX4.34
Ligand excluded by PLIPPX4.18: 14 residues within 4Å:- Chain B: G.30, I.31, G.34, L.35, S.38, T.40
- Chain D: T.142, Y.146, T.166, L.167, G.168
- Ligands: PX4.4, PX4.24, PX4.25
Ligand excluded by PLIPPX4.19: 13 residues within 4Å:- Chain B: P.79, W.80, F.83, F.111, V.114, S.125, I.128, I.131, P.132
- Ligands: PX4.20, PX4.21, PX4.22, PX4.23
Ligand excluded by PLIPPX4.20: 9 residues within 4Å:- Chain B: F.99
- Chain D: V.200, I.203, F.207
- Ligands: PX4.19, PX4.21, PX4.37, LMT.41, PX4.43
Ligand excluded by PLIPPX4.21: 7 residues within 4Å:- Ligands: PX4.19, PX4.20, PX4.22, 1N7.29, PX4.37, PX4.38, PX4.43
Ligand excluded by PLIPPX4.22: 5 residues within 4Å:- Ligands: PX4.19, PX4.21, PX4.23, 1N7.29, PX4.37
Ligand excluded by PLIPPX4.23: 8 residues within 4Å:- Chain B: K.77, P.79, L.82, F.83, F.86, I.90
- Ligands: PX4.19, PX4.22
Ligand excluded by PLIPPX4.24: 6 residues within 4Å:- Chain A: Y.197
- Ligands: PX4.18, PX4.25, PX4.46, PX4.47, PX4.48
Ligand excluded by PLIPPX4.25: 8 residues within 4Å:- Chain B: I.23, V.27, V.117, Q.119
- Ligands: 1N7.16, PX4.18, PX4.24, PX4.47
Ligand excluded by PLIPPX4.30: 18 residues within 4Å:- Chain A: M.141, T.142, G.168, E.169, F.171, Y.172, F.175, M.213, L.216
- Chain C: M.192, P.196, W.199, I.203, F.207
- Ligands: LMT.1, PX4.7, PX4.8, PX4.44
Ligand excluded by PLIPPX4.31: 14 residues within 4Å:- Chain B: T.142, Y.146, T.166, L.167, G.168
- Chain C: G.30, I.31, G.34, L.35, S.38, T.40
- Ligands: PX4.37, PX4.38, PX4.43
Ligand excluded by PLIPPX4.32: 13 residues within 4Å:- Chain C: P.79, W.80, F.83, F.111, V.114, S.125, I.128, I.131, P.132
- Ligands: PX4.33, PX4.34, PX4.35, PX4.36
Ligand excluded by PLIPPX4.33: 9 residues within 4Å:- Chain B: V.200, I.203, F.207
- Chain C: F.99
- Ligands: PX4.11, LMT.15, PX4.17, PX4.32, PX4.34
Ligand excluded by PLIPPX4.34: 7 residues within 4Å:- Ligands: 1N7.3, PX4.11, PX4.12, PX4.17, PX4.32, PX4.33, PX4.35
Ligand excluded by PLIPPX4.35: 5 residues within 4Å:- Ligands: 1N7.3, PX4.11, PX4.32, PX4.34, PX4.36
Ligand excluded by PLIPPX4.36: 8 residues within 4Å:- Chain C: K.77, P.79, L.82, F.83, F.86, I.90
- Ligands: PX4.32, PX4.35
Ligand excluded by PLIPPX4.37: 6 residues within 4Å:- Chain D: Y.197
- Ligands: PX4.20, PX4.21, PX4.22, PX4.31, PX4.38
Ligand excluded by PLIPPX4.38: 8 residues within 4Å:- Chain C: I.23, V.27, V.117, Q.119
- Ligands: PX4.21, 1N7.29, PX4.31, PX4.37
Ligand excluded by PLIPPX4.43: 18 residues within 4Å:- Chain B: M.141, T.142, G.168, E.169, F.171, Y.172, F.175, M.213, L.216
- Chain D: M.192, P.196, W.199, I.203, F.207
- Ligands: LMT.14, PX4.20, PX4.21, PX4.31
Ligand excluded by PLIPPX4.44: 14 residues within 4Å:- Chain A: T.142, Y.146, T.166, L.167, G.168
- Chain D: G.30, I.31, G.34, L.35, S.38, T.40
- Ligands: PX4.30, PX4.50, PX4.51
Ligand excluded by PLIPPX4.45: 13 residues within 4Å:- Chain D: P.79, W.80, F.83, F.111, V.114, S.125, I.128, I.131, P.132
- Ligands: PX4.46, PX4.47, PX4.48, PX4.49
Ligand excluded by PLIPPX4.46: 9 residues within 4Å:- Chain A: V.200, I.203, F.207
- Chain D: F.99
- Ligands: LMT.2, PX4.4, PX4.24, PX4.45, PX4.47
Ligand excluded by PLIPPX4.47: 7 residues within 4Å:- Ligands: PX4.4, 1N7.16, PX4.24, PX4.25, PX4.45, PX4.46, PX4.48
Ligand excluded by PLIPPX4.48: 5 residues within 4Å:- Ligands: 1N7.16, PX4.24, PX4.45, PX4.47, PX4.49
Ligand excluded by PLIPPX4.49: 8 residues within 4Å:- Chain D: K.77, P.79, L.82, F.83, F.86, I.90
- Ligands: PX4.45, PX4.48
Ligand excluded by PLIPPX4.50: 6 residues within 4Å:- Chain C: Y.197
- Ligands: PX4.7, PX4.8, PX4.9, PX4.44, PX4.51
Ligand excluded by PLIPPX4.51: 8 residues within 4Å:- Chain D: I.23, V.27, V.117, Q.119
- Ligands: PX4.8, 1N7.42, PX4.44, PX4.50
Ligand excluded by PLIP- 4 x NA: SODIUM ION(Non-functional Binders)
NA.13: 3 residues within 4Å:- Ligands: NA.26, NA.39, NA.52
No protein-ligand interaction detected (PLIP)NA.26: 3 residues within 4Å:- Ligands: NA.13, NA.39, NA.52
No protein-ligand interaction detected (PLIP)NA.39: 3 residues within 4Å:- Ligands: NA.13, NA.26, NA.52
No protein-ligand interaction detected (PLIP)NA.52: 3 residues within 4Å:- Ligands: NA.13, NA.26, NA.39
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Irie, K. et al., The structural basis of divalent cation block in a tetrameric prokaryotic sodium channel. Nat Commun (2023)
- Release Date
- 2023-07-26
- Peptides
- Ion transport protein: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 4 x 1N7: CHAPSO(Non-covalent)
- 36 x PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
- 4 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Irie, K. et al., The structural basis of divalent cation block in a tetrameric prokaryotic sodium channel. Nat Commun (2023)
- Release Date
- 2023-07-26
- Peptides
- Ion transport protein: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A - Membrane
-
We predict this structure to be a membrane protein.